[TAVI and coronary revascularization]

N Combaret1, M Bouchant1, P Motreff1

  • 1Service de cardiologie, centre hospitalier universitaire Gabriel-Montpied, 58, rue Montalembert, 63000 Clermont-Ferrand, France.

Annales De Cardiologie Et D'Angeiologie
|October 26, 2019
PubMed

Insights

Transcatheter aortic valve implantation (TAVI) can be complicated by coronary artery occlusion, particularly affecting the left main coronary artery. Pre-procedural imaging is crucial for identifying high-risk patients to prevent serious complications.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Severe aortic stenosis often coexists with coronary artery disease in inoperable patients.
  • Transcatheter aortic valve implantation (TAVI) is a primary treatment for severe aortic stenosis.
  • The impact of coronary lesions on survival after TAVI remains debated.

Purpose of the Study:

  • To review the implications of coronary artery disease in patients undergoing TAVI.
  • To discuss the risks and management of coronary artery occlusion during TAVI.
  • To outline strategies for percutaneous coronary intervention (PCI) post-TAVI.

Main Methods:

  • Review of existing literature on TAVI and coronary artery disease.
  • Analysis of factors contributing to coronary artery occlusion during TAVI.
  • Discussion of imaging techniques for risk stratification.
  • Evaluation of PCI techniques following TAVI.

Main Results:

  • Coronary revascularization may benefit selected proximal lesions before or during TAVI.
  • Periprocedural coronary artery occlusion is rare but carries a poor prognosis, often involving the left main coronary artery.
  • Risk factors for occlusion include short implantation distance and small aortic sinuses.
  • Late occlusions are linked to thrombus or fibrosis.
  • PCI success rates after TAVI are often low due to procedural challenges.

Conclusions:

  • Pre-TAVI imaging is vital for identifying high-risk cases and implementing preventive measures.
  • Management strategies for coronary artery disease in TAVI patients require careful consideration.
  • Specific PCI techniques are necessary for managing coronary interventions post-TAVI.

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...